Announcements Trials
Browse Landscape

Phase

Phase 2 63Phase NA 51Phase 3 41Phase 1 26Phase 1/2 13Phase EARLY_PHASE1 3Phase 4 2Phase 2/3 2

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Classical hematology 1

Conditions

Uterine Cervical Neoplasms 1Sarcoma 1Anemia 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Brachytherapy × Clear all
NCT04033081 2026-03-23

Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®

CivaTech Oncology

Phase 4 Active not recruiting
100 enrolled
Sarcoma

Sarcoma

NCT00046969 2013-05-30

Epoetin Beta in Treating Anemia in Patients With Cervical Cancer

National Cancer Institute (NCI)

Phase 4 Completed
450 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡